rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-12-25
|
pubmed:abstractText |
"In body tissue architecture" technology is a practical concept of regenerative medicine that uses the living recipient body's reaction to a foreign object as a reactor for autologous tissue organization. A novel autologous valved conduit was produced by creating a specially designed conduit-mold composite and elastomeric scaffold for this unique in vivo tissue engineering.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1550-5049
|
pubmed:author |
pubmed-author:HayashidaKyokoK,
pubmed-author:Ishibashi-UedaHatsueH,
pubmed-author:KandaKeiichiK,
pubmed-author:NakayamaYasuhideY,
pubmed-author:OhbaKenkichiK,
pubmed-author:OieTomonoriT,
pubmed-author:OkamotoYosihiroY,
pubmed-author:OnoyamaMasaakiM,
pubmed-author:SakaiOsamuO,
pubmed-author:TajikawaTsutomuT,
pubmed-author:WatanabeTaijiT,
pubmed-author:YakuHitoshiH
|
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
61-4
|
pubmed:meshHeading |
|
pubmed:articleTitle |
"In vivo tissue-engineered" valved conduit with designed molds and laser processed scaffold.
|
pubmed:affiliation |
Department of Bioengineering, National Cardiovascular Center Research Institute, Osaka, Japan.
|
pubmed:publicationType |
Journal Article
|